4//SEC Filing
Szela Mary T 4
Accession 0001415889-24-023320
CIK 0001826667other
Filed
Sep 11, 8:00 PM ET
Accepted
Sep 12, 7:06 PM ET
Size
5.2 KB
Accession
0001415889-24-023320
Insider Transaction Report
Form 4
Szela Mary T
DirectorCEO AND PRESIDENT
Transactions
- Purchase
Common Stock
2024-09-10$4.97/sh+5,000$24,850→ 369,862 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.91 to $4.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
TriSalus Life Sciences, Inc.
CIK 0001826667
Entity typeother
Related Parties
1- filerCIK 0001410289
Filing Metadata
- Form type
- 4
- Filed
- Sep 11, 8:00 PM ET
- Accepted
- Sep 12, 7:06 PM ET
- Size
- 5.2 KB